CancerPPD

This page gives details of Query peptides and provides facility to browse the same in CancerPPD database. Please wait while data is being retrieved. For more information see HELP page.

ID	PMID	SEQUENCE	NAME	LENGTH	ACTIVITY
1525	16637646	LLGDFFRKSKEK	LL-37(1-12)	12	Not Available
1526	16637646	IGKEFKRIVQRIKDFLRNLVPRTES	LL-37(13-37)	25	LC₅₀=39 µM
1527	16637646	FKRIVQRIKDFLRNLV	LL-37(17-32)b	16	LC₅₀=30 µM
1528	16637646	FKRIVQRIKDFLR	LL-37(17-29)	13	LC₅₀=60 µM
1529	16637646	LLGDFKRIVQRIKDF	LL-37(1-4,17-27)	15	Not Available
1530	16637646	FKRiVQRiKDFlRNLV	dLL-37(17-32)c	16	Not Available
1531	16637646	LLGDFFRKSKEK	LL-37(1-12)	12	Not Available
1532	16637646	IGKEFKRIVQRIKDFLRNLVPRTES	LL-37(13-37)	25	LC₅₀=40 µM
1533	16637646	FKRIVQRIKDFLRNLV	LL-37(17-32)b	16	LC₅₀=30 µM
1534	16637646	FKRIVQRIKDFLR	LL-37(17-29)	13	LC₅₀=57 µM
1535	16637646	LLGDFKRIVQRIKDF	LL-37(1-4,17-27)	15	Not Available
1536	16637646	FKRIVQRIKDFLRNLV	dLL-37(17-32)c	16	Not Available
1537	16637646	LLGDFFRKSKEK	LL-37(1-12)	12	Not Available
1538	16637646	IGKEFKRIVQRIKDFLRNLVPRTES	LL-37(13-37)	25	LC₅₀=38 µM
1539	16637646	FKRIVQRIKDFLRNLV	LL-37(17-32)b	16	LC₅₀=25 µM
1540	16637646	FKRIVQRIKDFLR	LL-37(17-29)	13	LC₅₀=55 µM
1541	16637646	LLGDFKRIVQRIKDF	LL-37(1-4,17-27)	15	Not Available
1542	16637646	FKRIVQRIKDFLRNLV	dLL-37(17-32)c	16	Not Available
1543	22073006	GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE	Pardaxin	33	IC₅₀=15.74 µg/ml
1544	22073006	GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE	Pardaxin	33	IC₅₀=15.40 µg/ml
3198	22184121	MTLTG	BPP-II	5	NA
3208	22184121	MTLTG	BPP-II	5	NA
3347	11943716	Not Available	Hα-Defensin HNPs-1	Not Available	Inhibition at 12.5 µg/ml
3348	11943716	Not Available	Hα-Defensin HNPs-2	Not Available	Inhibition at 12.5 µg/ml
3349	11943716	Not Available	Hα-Defensin HNPs-3	Not Available	Inhibition at 12.5 µg/ml
3817	22963485	MNFQQRLQSLWTLARPFCPPLLATASQMQMVVLPCLGFTLLLWSQVSG AQGQEFHFGPCQVKGVVPQKLWEAFWAVKDTMQAQDNITSARLLQQEVLQ NVSDAESCYLVHTLLEFYLKTVFKNYHNRTVEVRTLKSFSTLANN FVLIVSQLQPSQENEMFSIRDSAHRRFLLFRRA FKQL	wtmda-7/IL-24	206	Cell viability(% of control)= 0.5 at concentration 8 µg/ml
3819	22963485	MNFQQRLQSLWTLARPFCPPLLATASQMQMVVLPCLGFTLLLWSQVSG AQGQEFHFGPCQVKGVVPQKLWEAFWAVKDTMQAQDNITSARLLQQEVLQ NVSDAESCYLVHTLLEFYLKTVFKNYHNRTVEVRTLKSFSTLANN FVLIVSQLQPSQENEMFSIRGDSAHRRFLLFRRAF KQLDVEAALTKALGEVDILLTWMQKFYKL	RGD-mda-7	207	Cell viability(% of control)= 0.5 at concentration 8 µg/ml
3821	22963485	MNFQQRLQSLWTLARPFCPPLLATASQMQMVVLPCLGFTLLLWSQVSG AQGQEFHFGPCQVKGVVPQKLWEAFWAVKDTMQAQDNITSARLLQQEVLQ NVSDAESCYLVHTLLEFYLKTVFKNYHNRTVEVRTLKSFSTLANNF VLIVSQLQPSQENEMFSIRDSAHRRFLLFRRAF KQL	wtmda-7/IL-24	206	Apoptotic rate(%)= >30% at concentration of 8 µg/ml
3824	22963485	MNFQQRLQSLWTLARPFCPPLLATASQMQMVVLPCLGFTLLLWSQVSG AQGQEFHFGPCQVKGVVPQKLWEAFWAVKDTMQAQDNITSARLLQQEVLQ NVSDAESCYLVHTLLEFYLKTVFKNYHNRTVEVRTLKSFSTLANNF VLIVSQLQPSQENEMFSIRDSAHRRFLLFRRAFKQL	RGD-mda-7	207	Apoptotic rate(%)= >50% at concentration of 8 µg/ml
3834	20515045	IVRRADRAAVP	ES-2	11	60% inhibition at 2.5µg/ml
3835	20515045	IVRRADRAAVP	ES-2	11	60% inhibition at 5µg/ml
3836	20515045	IVRRADRAAVP	ES-2	11	60% inhibition at 10µg/ml
3837	20515045	ACDCRGDCFCGGGGIVRRADRAAVP	AP	25	50% inhibition at 2.5µg/ml
3838	20515045	ACDCRGDCFCGGGGIVRRADRAAVP	AP	25	40% inhibition at 5µg/ml
3839	20515045	ACDCRGDCFCGGGGIVRRADRAAVP	AP	25	75% inhibition at 10µg/ml
3840	20515045	ACDCRGDCFCGGGGIVRRADRAAVP	AP(O)	25	40% inhibition at 2.5µg/ml
3841	20515045	ACDCRGDCFCGGGGIVRRADRAAVP	AP(O)	25	42% inhibition at 5µg/ml
3842	20515045	ACDCRGDCFCGGGGIVRRADRAAVP	AP(O)	25	52% inhibition at 10µg/ml
3847	16722632	YA*	8	2	14.2% inhibition at 10^-6
3848	16722632	YA*	8	2	19.7% inhibition at 10^-5
3849	16722632	YA*	8	2	24.9% inhibition at 10^-4
3850	16722632	YA*	8	2	30.4% inhibition at 10^-3
3851	16722632	YA*	8	2	10% inhibition at 10^-5
3852	16722632	YA*	8	2	8.2% inhibition at 10^-4
3853	16722632	YA*	8	2	36.1% inhibition at 10^-3
4174	14991605	KIFGSLAFL	p369-CTL-A2xneu	9	0.1% Inhibition at 10^-10 M
4175	14991605	KIFGSLAFL	p369-CTL-A2xneu	9	1% Inhibition at 10^-9 M
4176	14991605	KIFGSLAFL	p369-CTL-A2xneu	9	5% Inhibition at 10^-8 M
4177	14991605	KIFGSLAFL	p369-CTL-A2xneu	9	10% Inhibition at 10^-7 M
4178	14991605	KIFGSLAFL	p369-CTL-A2xneu	9	20% Inhibition at 10^-6 M
4179	14991605	KIFGSLAFL	p369-CTL-A2xFVB	9	8% Inhibition at 10^-10 M
4180	14991605	KIFGSLAFL	p369-CTL-A2xFVB	9	25% Inhibition at 10^-9 M
4181	14991605	KIFGSLAFL	p369-CTL-A2xFVB	9	80% Inhibition at 10^-8 M
4182	14991605	KIFGSLAFL	p369-CTL-A2xFVB	9	85% Inhibition at 10^-7 M
4183	14991605	KIFGSLAFL	p369-CTL-A2xFVB	9	92% Inhibition at 10^-6 M
4184	15313924	HHPHG	HHPHG	5	IC₅₀=92 µM
4185	15313924	HHPHGHHPHG	(HHPHG)2	10	IC₅₀=11.6 µM
4186	15313924	HHPHGHHPHG	(HHPHG)2	10	IC₅₀=26.9 µM
4187	15313924	HHPHGHHPHGHHPHG	(HHPHG)3	15	IC₅₀=1.25 µM
4188	15313924	HHPHGHHPHGHHPHG	(HHPHG)3	15	IC₅₀=1.56 µM
4189	15313924	HHPHGHHPHGHHPHGHHPHG	(HHPHG)4	20	IC₅₀=0.256 µM
4190	15313924	HHPHGHHPHGHHPHGHHPHG	(HHPHG)4	20	IC₅₀=0.245 µM
4233	16568093	rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK	r8-BadBH3	35	20% apoptosis at 10 µM
4234	16568093	rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK	r8-BadBH3	35	>50% apoptosis at 20 µM
4235	16568093	rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK	r8-BadBH3	35	30% apoptosis at 50 µM
4236	16568093	rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK	r8-BadBH3	35	15% apoptosis at 10 µM
4237	16568093	rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK	r8-BadBH3	35	20% apoptosis at 20 µM
4238	16568093	rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK	r8-BadBH3	35	50% apoptosis at 50 µM
4245	16568093	rrrrrrrrGEDIIRNIARHLAQVGDSMDR	r8-BidBH3	29	43% apoptosis at 10 µM
4246	16568093	rrrrrrrrGEDIIRNIARHLAQVGDSMDR	r8-BidBH3	29	46% apoptosis at 20 µM
4247	16568093	rrrrrrrrGEDIIRNIARHLAQVGDSMDR	r8-BidBH3	29	79% apoptosis at 50 µM
4248	16568093	rrrrrrrrGEDIIRNIARHLAQVGDSMDR	r8-BidBH3	29	23% apoptosis at 10 µM
4249	16568093	rrrrrrrrGEDIIRNIARHLAQVGDSMDR	r8-BidBH3	29	35% apoptosis at 20 µM
4250	16568093	rrrrrrrrGEDIIRNIARHLAQVGDSMDR	r8-BidBH3	29	55% apoptosis at 50 µM
4257	16568093	rrrrrrrrGEDIIRNIARHAAQVGASMDR	r8-BidBH3Alt	29	1% apoptosis at 10 µM
4258	16568093	rrrrrrrrGEDIIRNIARHAAQVGASMDR	r8-BidBH3Alt	29	2% apoptosis at 20 µM
4259	16568093	rrrrrrrrGEDIIRNIARHAAQVGASMDR	r8-BidBH3Alt	29	3% apoptosis at 50 µM
4260	16568093	rrrrrrrrGEDIIRNIARHAAQVGASMDR	r8-BidBH3Alt	29	0% apoptosis at 10 µM
4261	16568093	rrrrrrrrGEDIIRNIARHAAQVGASMDR	r8-BidBH3Alt	29	1% apoptosis at 20 µM
4262	16568093	rrrrrrrrGEDIIRNIARHAAQVGASMDR	r8-BidBH3Alt	29	2% apoptosis at 50 µM
4355	17698251, 18957441	FLIGMTQGLICLITRKC	Dybowskin-2	17	Not Available
4356	19254736, 18957441	FLPAIVGAAAKFLPKIFCAISKKC	Brevinin-1BLa	24	Not Available
4357	19254736, 18957441	FLPIIAGAAAKVVEKIFCAISKKC	Brevinin-1BLa	24	Not Available
4358	19254736, 18957441	FLPIIAGAAAKVVQKIFCAISKKC	Brevinin-1BLa	24	Not Available
4359	19254736, 18957441	FLPIIAGIAAKFLPKIFCTISKKC	Brevinin-1BLa	24	Not Available
4360	19254736, 18957441	FLPIIAGVAAKVLPKIFCAISKKC	Brevinin-1BLa	24	Not Available
4361	19254736, 18957441	FLPVIAGVAANFLPKLFCAISKKC	Brevinin-1BLa	24	Not Available
4362	19254736, 18957441	GLMDTIKGVAKTVAASWLDKLKCKITGC	Ranatuerin-2Ya	28	Not Available
4363	9022710, 18957441	FVQWFSKFLGRIL	Temporin L	13	Not Available
4364	16713189, 18957441	FLPILASLAAKFGPKLFCLVTKKC	Brevinin-1BYa	24	Not Available
4365	21882228, 18957441	AWKLFDDGV	Cr-ACP1	9	Not Available
4366	22467870, 18957441	IPCGESCVWIPCITAIAGCSCKNKVCYT	ChaC7	29	Not Available
4367	22467870, 18957441	AIPCGESCVWIPCISTVIGCSCSNKVCYR	Chassatide C8	29	Not Available
4368	22467870, 18957441	IPCGESCVWIPCISGMFGCSCKDKVCYS	ChaC11	29	Not Available
4369	22467870, 18957441	GASCGETCFTGICFTAGCSCNPWPTCTRN	Chassatide C4	29	Not Available
4370	22467870, 18957441	GDACGETCFTGICFTAGCSCNPWPTCTRN	Chassatide C4	29	Not Available
4371	22467870, 18957441	GEYCGESCYLIPCFTPGCYCVSRQCVNKN	Chassatide C10	29	Not Available
4372	22467870, 18957441	GIPCAESCVWIPPCTITALMGCSCKNNVCYNN	Chassatide C2	32	Not Available
4373	21723349, 18957441	GSIPCGESCVFIPCISAVIGCSCSNKVCYKN	Viphi E	31	Not Available
4374	21723349, 18957441	GSIPCGESCVFIPCISSVIGCACKSKVCYKN	Viphi F	31	Not Available
4375	21723349, 18957441	GSIPCGESCVFIPCISAIIGCSCSSKVCYKN	Viphi F	31	Not Available
4376	21723349, 18957441	GIPCGESCVFIPCLTSAIDCSCKSKVCYRN	Mram 8	30	Not Available
4377	21723349, 18957441	GLPVCGETCVGGTCNTPGCACSWPVCTRN	Viba 15	29	Not Available
4378	21723349, 18957441	GLPVCGETCVGGTCNTPGCGCSWPVCTRN	Viba17	29	Not Available
4379	21723349, 18957441	GSIPCEGSCVFIPCISAIIGCSCSNKVCYKN	Viphi G	31	Not Available
4380	10600388, 18957441	GIPCGESCVWIPCISSAIGCSCKSKVCYRN	Cycloviolacin O2	30	Not Available
4381	21596752, 18957441	GLPTCGETCTLGTCYVPDCSCSWPICMKN	Cliotide T3	29	Not Available
4382	21596752, 18957441	GIPCGESCVFIPCITGAIGCSCKSKVCYRN	Cliotide T1	30	Not Available
4383	21596752, 18957441	GIPCGESCVFIPCITAAIGCSCKSKVCYRN	Cliotide T4	30	Not Available
4384	21596752, 18957441	GEFLKCGESCVQGECYTPGCSCDWPICKKN	Cliotide T2	30	Not Available
4385	6385903, 18957441	GETDPNTQLLNDLGNNMAWGAALGAPGGLGSAALGAAGGALQTVGQ GLIDHGPVNVFIPVLIGPSWNGSGSGYNSATSSSGSGS	Microcin E492	84	Not Available
4386	22100226, 18957441	GTGLPMSERRKIMLMMR	Macropin 2	17	Not Available
4387	22100226, 18957441	GFGMALKLLKKVL	Macropin 1	13	Not Available
4388	15207717, 18957441	GFKDLLKGAAKALVKTVLF	Ascaphin-8	19	Not Available
4389	9620615, 18957441	GFVDFLKKVAGTIANVVT	Maculatin 2.1	18	Not Available
4390	9620615, 18957441	GLFVGLAKVAAHNNPAIAEHFQA	Maculatin 1.2	23	Not Available
4391	9620615, 18957441	GLFVGVLAKVAAHVVPAIAEHF	Maculatin 1.1	22	Not Available
4392	9620615, 18957441	GLLQTIKEKLESLESLAKGIVSGIQA	Maculatin 3.1	26	Not Available
4393	8910461, 18957441	GRFKRFRKKFKKLFKKLSPVIPLLHLG	BMAP-27	27	Not Available
4394	8910461, 18957441	GGLRSLGRKILRAWKKYGPIIVPIIRIG	BMAP-28	28	Not Available
4395	20575512, 18957441	KLCGETCFKFKCYTPGCSCSYPFCK	Psyle C	25	Not Available
4396	20575512, 18957441	GVIPCGESCVFIPCISSVLGCSCKNKVCYRD	Psyle E	31	Not Available
4397	20575512, 18957441	GIACGESCVFLGCFIPGCSCKSKVCYFN	Psyle A	28	Not Available
4398	11835991, 18957441	ILGPVISTIGGVLGGLLKNL	Maximin H1	27	Not Available
4399	11835991, 18957441	GIGGKILSGLKTALKGAAKELASTYLH	Maximin 3	27	Not Available
4400	11835991, 18957441	GIGGVLLSAGKAALKGLAKVLAEKYAN	Maximin 4	27	Not Available
4401	11835991, 18957441	GIGTKILGGVKTALKGALKELASTYAN	Maximin 1	27	Not Available
4402	20198492, 18957441	GMWSKILGHLIR	Halictine 1	12	Not Available
4403	20198492, 18957441	GKWMSLLKHILK	Halictine 2	12	Not Available
4404	10951191, 18957441	GLFDIIKKIAESI	Aurein 1.1	13	Not Available
4405	10504394, 18957441	GLFDIIKKVASVIGGL	Citropin 1.3	16	Not Available
4406	10504394, 18957441	GLFDIIKKVASVVGGL	Citropin 1.2	16	Not Available
4407	10951191, 18957441	GLFDIVKKVVGAIGSL	Aurein 2.3	16	Not Available
4408	10951191, 18957441	GLFDIVKKVVGALGSL	Aurein 2.2	16	Not Available
4409	10951191, 18957441	GLFDIVKKVVGTLAGL	Aurein 2.4	16	Not Available
4410	9516047, 18957441	GLFGVLGSIAKHVLPHVVPVIAEK	Caerin 1.9	24	Not Available
4411	9230483, 18957441	GLFKVLGSVAKHLLPHVAPVIAEK	Caerin 1.7	24	Not Available
4412	9230483, 18957441	GLFKVLGSVAKHLLPHVVPVIAEK	Caerin 1.8	24	Not Available
4413	9230483, 18957441	GLFSVLGAVAKHVLPHVVPVIAEK	Caerin 1.6	24	Not Available
4414	10951191, 18957441	GLLDIVKKVVGAFGSL	Aurein 2.1	16	Not Available
4415	22771617, 18957441	GLLGLLGSVVSHVLPAITQHL	Maculatin 1.4	21	Not Available
4416	22771617, 18957441	GLLGLLGSVVSHVVPAIVGHF	Maculatin 1.3	21	Not Available
4417	11738090, 18957441	GLLGPLLKIAAKVGSNLL	CPF-ST3	18	Not Available
4418	18191970, 18957441	GTFPCGESCVFIPCLTSAIGCSCKSKVCYKN	Vibi G	31	Not Available
4419	12235362, 18957441	HGVSGHGQHGVHG	Alloferon 1	13	Not Available
4420	7916722, 18957441	GWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLK	Cecropin 2	39	Not Available
4421	10075760, 18957441	GVPICGETCTLGTCYTAGCSCSWPVCTRN	Varv peptide F	29	Not Available
4422	18191970, 18957441	GIPCAESCVWIPCTVTALIGCGCSNKVCYN	Vibi E	30	Not Available
4423	18191970, 18957441	GLLPCAESCVYIPCLTTVIGCSCKSKVCYKN	Vibi H	31	Not Available
4424	9266696, 18957441	GLLSVLGSVAKHVLPHVVPVIAEHL	Caerin 1.1	25	Not Available
4425	10601876, 18957441	GLLSVLGSVAKHVLPHVVPVIAEKL	Caerin 1.10	25	Not Available
4435	10942757, 18957441	ECRRLCYKQRCVTYCRGR	Gomesin	18	Not Available
4436	12581207, 18957441	FFGWLIKGAIHAGKAIHGLIHRRRH	Chrysophsin-1	25	Not Available
4437	11713517, 18957441	FFHHIFRGIVHVGKTIHRLVTG	Piscidin 1	22	Not Available
4438	16129513, 18957441	IDWKKLLDAAKQIL	Polybia-MPI	14	Not Available
4439	19341344, 18957441	ILPILSLIGGLLGK	Temporin-1CEb	17	Not Available
4440	15700822, 18957441	KSCCKNTTGRNIYNTCRFAGGSRERCAKLSGCKIISAST CPSDYPK	Viscotoxin B2	46	Not Available
4441	5719166, 18957441	KSCCPNTTGRNIYNACRLTGAPRPTCAKLSGCKIISGST CPSDYPK	Viscotoxin A3	46	Not Available
4442	9348108, 18957441	KSCCPNTTGRNIYNTCRFAGGSRERCAKLSGCKIISAST CPSDYPK	Viscotoxin C1	46	Not Available
4443	9348108, 18957441	KSCCPNTTGRNIYNTCRLTGSSRETCAKLSGCKIISAST CPSNYPK	Viscotoxin A1	46	Not Available
4444	9348108, 18957441	KSCCPNTTGRNIYNTCRFGGGSREVCARISGCKIISAST CPSDYPK	Viscotoxin 1-PS	46	Not Available
4445	9348108, 18957441	KSCCPNTTGRNIYNTCRFGGGSRQVCASLSGCKIISAST CPSDYPK	Viscotoxin A2	46	Not Available
4446	1710983, 18957441	KSCCPNTTGRNIYNTCRLGGGSRERCASLSGCKIISAST CPSDYPK	Viscotoxin B	46	Not Available
4447	3985614, 18957441	KSCCRNTWARNCYNVCRLPGTISREICAKKCDCKIISGT TCPSDYPK	Pyrularia thionin	47	Not Available
4448	8245827, 18957441	KSSAYSLQMGATAIKQVKKLFKKWGW	Plantaricin A	26	Not Available
4449	16269344, 18957441	KTCENLADTFRGPCFATSNC	Lunatusin	20	Not Available
4450	15949629, 18957441	KTCENLADTY	Sesquin	10	Not Available
4451	8555423, 18957441	LKLKSIVSWAKKVL	Mastoparan B	14	Not Available
4452	17561225, 18957441	GLWSKIKEAAKAAGKAALNAVTGLVNQGDQPS	Phylloseptin	32	Not Available
4453	17561225, 18957441	LLGMIPLAISAISALSKL	Phylloseptin-L1	32	Not Available
4454	17067680, 18957441	GIKCRFCCGCCTPGICGVCCRF	hepcidin TH1-5	22	Not Available
4461	10531277, 18957441	YKQCHKKGGHCFPKEKICLPPSSDFGKMDCRWRWK CCKKGSG	Crotamine	42	Not Available
4576	21928125	LIAHNQVRQV	p85	10	Not Available
4577	21928125	GVGSPYVSRLLGICL	p776	15	Not Available

CancerPPD :Database of Anticancer peptides and Proteins

Browse Result page of CancerPPD